Abeona Therapeutics (ABEO) Shares Issued (2010 - 2026)
Abeona Therapeutics' (ABEO) quarterly Shares Issued came in at $184426.0 in Q1 2026, down 65.31% year-on-year from $531700.0 in Q1 2025, and up 4.78% quarter-over-quarter from $176019.0 in Q4 2025.
Abeona Therapeutics (ABEO) Shares Issued (2010 - 2026) Analysis & Trends
Abeona Therapeutics' Shares Issued history runs 12 years deep, the most recent figure standing at $184426.0 for Q1 2026.
- On a quarterly basis, Shares Issued fell 65.31% year-over-year to $184426.0 in Q1 2026; TTM through Mar 2026 was $184426.0, a 65.31% decrease from a year earlier, with the FY2025 full-year figure at $176019.0, changed 0.47% from the prior year.
- Shares Issued grew to $184426.0 in Q1 2026 per ABEO's latest filing, from $176019.0 in the prior quarter.
- Across five years, Shares Issued topped out at $531700.0 in Q1 2025 and bottomed at $151580.0 in Q2 2024.
- The 5-year median for Shares Issued is $177138.0 (2024), against an average of $213402.9.
- Across the five-year window, Shares Issued jumped 197.04% in 2025 and sank 65.31% in 2026, its largest moves.
- Year by year, Shares Issued stood at $240770.0 in 2022, then fell by 25.65% to $179001.0 in 2023, then retreated by 1.2% to $176857.0 in 2024, then retreated by 0.47% to $176019.0 in 2025, then gained by 4.78% to $184426.0 in 2026.
- Per Business Quant, the three latest ABEO Shares Issued figures stand at $184426.0 (Q1 2026), $176019.0 (Q4 2025), and $174792.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 19.44 Mn |
| 10 | Abeona Therapeutics | 107.85 Mn | -60.42 Mn | 6.02 Mn | 184,426.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 184,426.00 |
| Mar 31, 2026 | 184,426.00 |
| Dec 31, 2025 | 176,019.00 |
| Dec 31, 2025 | 176,019.00 |
| Sep 30, 2025 | 174,792.00 |
| Sep 30, 2025 | 174,792.00 |
| Jun 30, 2025 | 176,148.00 |
| Jun 30, 2025 | 176,148.00 |
| Mar 31, 2025 | 531,700.00 |
| Mar 31, 2025 | 531,700.00 |
| Dec 31, 2024 | 176,857.00 |
| Dec 31, 2024 | 176,857.00 |
| Sep 30, 2024 | 177,138.00 |
| Sep 30, 2024 | 177,138.00 |
| Jun 30, 2024 | 151,580.00 |
| Jun 30, 2024 | 151,580.00 |
| Mar 31, 2024 | 179,001.00 |
| Mar 31, 2024 | 179,001.00 |
| Dec 31, 2023 | 179,001.00 |
| Dec 31, 2023 | 179,001.00 |